2019-05-01 |
10 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,161,926 B2 . (Gaza, Anne) (… 2019
23 May 2022
1:19-cv-00658
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-11-12 |
156 |
Notice of Service |
Osborne, Ph.D. Regarding Validity of U.S. Patent No. 9,517,219 filed by Almirall, LLC.(Raucci, Anthony)… 2019
23 May 2022
1:19-cv-00658
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2021-01-24 |
167 |
Order - -Memorandum and Order |
Almirall sued Amneal in 2019, asserting U.S. Patent No. 9,517,219 in an
attempt to stop Amneal from obtaining… I
Almirall owns U.S. Patent No. 9,517,219, which covers ACZONE (dapsone) Gel,
7.5%…language of the claims of patent, the patent’s specification
and the patent’s prosecution history (i.…the
’219 patent and the patent at issue in Geneva Pharms—infringement of the ’219 patent
does not … A
“[A] patent claim is that ‘portion of the patent document that defines the scope |
External link to document |
2022-05-23 |
189 |
Patent/Trademark Report to Commissioner of Patents |
Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,517,219 B2 ; 9,161,926 B2. (smg) (… 2019
23 May 2022
1:19-cv-00658
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2019-04-09 |
4 |
Patent/Trademark Report to Commissioner of Patents |
the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,517,219 B2. (myr) (Entered:… 2019
23 May 2022
1:19-cv-00658
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-03-20 |
67 |
Stipulation of Dismissal |
Dismissal of Counterclaims Relating to U.S. Patent No. 9,161,926 by Amneal Pharmaceuticals LLC. (Gaza, Anne… 2019
23 May 2022
1:19-cv-00658
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |
2020-03-24 |
71 |
Order |
invalidity and non-infringement of U.S. Patent No. 9,161,926, set forth in its First and Second Counterclaims… 2019
23 May 2022
1:19-cv-00658
835 Patent - Abbreviated New Drug Application(ANDA)
None |
External link to document |